Gigi Georgiana Huang

Array ( [id] => 5689079 [patent_doc_number] => 20060287394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Composition and method for treating macular disorders' [patent_app_type] => utility [patent_app_number] => 10/557170 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287394.pdf [firstpage_image] =>[orig_patent_app_number] => 10557170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409640 [patent_doc_number] => 20040176290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration' [patent_app_type] => new [patent_app_number] => 10/484550 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10875 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176290.pdf [firstpage_image] =>[orig_patent_app_number] => 10484550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7418753 [patent_doc_number] => 20040228820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Compositions comprising an amidine and an alkane polyol' [patent_app_type] => new [patent_app_number] => 10/841193 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8233 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228820.pdf [firstpage_image] =>[orig_patent_app_number] => 10841193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667627 [patent_doc_number] => 20060172977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage' [patent_app_type] => utility [patent_app_number] => 10/549961 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172977.pdf [firstpage_image] =>[orig_patent_app_number] => 10549961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7148311 [patent_doc_number] => 20040170666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Eye coverings' [patent_app_type] => new [patent_app_number] => 10/477645 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8357 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170666.pdf [firstpage_image] =>[orig_patent_app_number] => 10477645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041231 [patent_doc_number] => 20070093513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Agent for repairing corneal perception' [patent_app_type] => utility [patent_app_number] => 10/553320 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7041 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093513.pdf [firstpage_image] =>[orig_patent_app_number] => 10553320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786582 [patent_doc_number] => 20060205709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof' [patent_app_type] => utility [patent_app_number] => 10/553120 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30180 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205709.pdf [firstpage_image] =>[orig_patent_app_number] => 10553120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142465 [patent_doc_number] => 20070004681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods for treating arthritic conditions' [patent_app_type] => utility [patent_app_number] => 10/550532 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10352 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004681.pdf [firstpage_image] =>[orig_patent_app_number] => 10550532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265168 [patent_doc_number] => 20040242704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Stabilized mutant opsin proteins' [patent_app_type] => new [patent_app_number] => 10/801078 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10945 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242704.pdf [firstpage_image] =>[orig_patent_app_number] => 10801078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643366 [patent_doc_number] => 20060281821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Retinoid replacements and opsin agonists and methods for the use thereof' [patent_app_type] => utility [patent_app_number] => 10/548612 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21564 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281821.pdf [firstpage_image] =>[orig_patent_app_number] => 10548612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172563 [patent_doc_number] => 20050203086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of treatment using an EP2 selective receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/793530 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44445 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203086.pdf [firstpage_image] =>[orig_patent_app_number] => 10793530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379048 [patent_doc_number] => 20040220270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods and composition of treating glaucoma by modulating tyrosinase/L-DOPA pathway' [patent_app_type] => new [patent_app_number] => 10/793604 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8942 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220270.pdf [firstpage_image] =>[orig_patent_app_number] => 10793604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022226 [patent_doc_number] => 20070148192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Stable ophthalmic composition' [patent_app_type] => utility [patent_app_number] => 10/546417 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148192.pdf [firstpage_image] =>[orig_patent_app_number] => 10546417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275155 [patent_doc_number] => 20040234606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Localized vaginal delivery without detrimental blood levels' [patent_app_type] => new [patent_app_number] => 10/778151 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7309 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234606.pdf [firstpage_image] =>[orig_patent_app_number] => 10778151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834302 [patent_doc_number] => 20060246132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Sustained release formulations of venlafaxine' [patent_app_type] => utility [patent_app_number] => 10/544624 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3140 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246132.pdf [firstpage_image] =>[orig_patent_app_number] => 10544624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866138 [patent_doc_number] => 20060100269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders' [patent_app_type] => utility [patent_app_number] => 10/543361 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6399 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100269.pdf [firstpage_image] =>[orig_patent_app_number] => 10543361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802169 [patent_doc_number] => 20060036220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye' [patent_app_type] => utility [patent_app_number] => 10/540835 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20060036220.pdf [firstpage_image] =>[orig_patent_app_number] => 10540835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727627 [patent_doc_number] => 20060058388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods for treating ocular diseases via introxide and or polyhydroxy acid containing compounds' [patent_app_type] => utility [patent_app_number] => 10/541348 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1944 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058388.pdf [firstpage_image] =>[orig_patent_app_number] => 10541348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7326642 [patent_doc_number] => 20040138610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Active agent delivery device having composite members' [patent_app_type] => new [patent_app_number] => 10/745995 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6800 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138610.pdf [firstpage_image] =>[orig_patent_app_number] => 10745995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769417 [patent_doc_number] => 20060020001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Use of cathepsin k inhibitors for the treatment of glaucoma' [patent_app_type] => utility [patent_app_number] => 10/537052 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7188 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020001.pdf [firstpage_image] =>[orig_patent_app_number] => 10537052 [rel_patent_id] =>[rel_patent_doc_number] =>)